Danaher Corporation (DHR) has seen a myriad of investment activities, both buying and selling, by numerous firms such as Aberdeen Group, Conning Inc., Eastern Bank, Callan Family Office, Trust Co. of Toledo, and more. The valuation of the corporation's shares has been a cause for concern as it declined by
12% year-to-date. Meanwhile, DHR is anticipated to announce its FQ3 results on October 21. Other important occurrences include investment and stake adjustments, with certain companies such as Aberdeen Group plc, Conning Inc., and Lmcg Investments showing increased interest, while others such as Dohj LLC, Rice Partnership, and Broderick Brian C chose to reduce their holdings. Investment additions by the likes of 111 Capital and Robeco Institutional Asset Management are notable, and various downgrades and adjustments in target prices have been made by entities such as BofA and Rothschild & Co. Also highlighted is the company's
AI push, likely tariff benefits, and recent product launches. The corporation's future seems to hinge largely on its life sciences segment amidst its reduced shareholdings.
Danaher Corporation DHR News Analytics from Sun, 13 Apr 2025 07:00:00 GMT to Sat, 11 Oct 2025 14:33:43 GMT -
Rating -1
- Innovation 6
- Information 7
- Rumor 3
